Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Hospital Radiopharmacy in the UK

James R. Ballinger  1
Ralph McCready  1 , Gopinath Gnanasegaran  2 , Jamshed B. Bomanji  3
, editors.
In: A History of Radionuclide Studies in the UK: 50th Anniversary of the British Nuclear Medicine Society [Internet]. Cham (CH): Springer; 2016. Chapter 17.
.
Affiliations
Free Books & Documents
Review

Hospital Radiopharmacy in the UK

James R. Ballinger.
Free Books & Documents

Excerpt

In the early days, hospital radiopharmacy usually fell under the remit of medical physics and regulation was somewhat informal. An early guideline on preparation of radiopharmaceuticals in hospitals was published by the British Institute of Radiology in 1975. With the loss of Crown Immunity in 1991, radiopharmacy came under the full scrutiny of the MHRA and standards have been continually tightened since then. Indeed, the UK led the world in this, for which the world does not thank us. Members of the UK community continue to play an important role nationally and internationally in advancing the practice of hospital radiopharmacy. This chapter explores the evolution of hospital radiopharmacy in the UK.

PubMed Disclaimer

Sections

References

    1. Garnett ES, Parsons V, Veall N. Measurement of glomerular filtration-rate in man using a 51Cr-edetic-acid complex. Lancet. 1967;1:818–9. - PubMed
    1. Taylor DM, Brock M, Frier M, Joshi VK, Jewkes R, Keeling DH, Hughes D, Little WA, Smith PH, Trott NG, Watson IA, Whately TL, Wood EJ. Guidelines for the preparation of radiopharmaceuticals in hospitals. London: British Institute of Radiology; 1975.
    1. Ell PJ, Jarritt PH, Cullum I, Hocknell JM, Costa DC, Lui D, Jewkes RF, Steiner TJ, Nowotnik DP, Pickett RD, et al. Regular cerebral blood flow mapping with 99mTc-labelled compound. Lancet. 1985;2:50–1. - PubMed
    1. Sharp PF, Smith FW, Gemmell HG, Lyall D, Evans NT, Gvozdanovic D, Davidson J, Tyrrell DA, Pickett RD, Neirinckx RD. Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. J Nucl Med. 1986;27:171–7. - PubMed
    1. Higley B, Smith FW, Smith T, Gemmell HG, Das Gupta P, Gvozdanovic DV, Graham D, Hinge D, Davidson J, Lahiri A. Technetium-99m-1,2-bis[bis(2-ethoxyethyl)-phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med. 1993;34:30–8. - PubMed

LinkOut - more resources